We are live on ! Find out more
BIOSU

BioPlus Acquisition Corp. Unit
BIOSU

Delisted

BIOSU was delisted on the 6th of October, 2023.

Back to rankings

2 hedge funds and large institutions have $188K invested in BioPlus Acquisition Corp. Unit in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% less funds holding

Funds holding: 9 → 2 (-7)

98% less capital invested

Capital invested by funds: $9.14M → $188K (-$8.96M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-7
Holders Change %
-77.78%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
-$5.24M
2
RCM
Rivernorth Capital Management
Florida
-$1.04M
3
SIA
Schechter Investment Advisors
Michigan
-$954K
4
Walleye Capital
Walleye Capital
New York
-$525K
5
BCL
Bracebridge Capital LLC
Massachusetts
-$524K

BIOSU Hedge Fund Activity: Q2 2023 in Review

2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q2 2023, worth a combined $188K — down 98% from $9.14M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BIOSU and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was HGC Investment Management, exiting entirely with an estimated $5.24M sold.

  • 2 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q2 2023, down from 9 in Q1 2023.
  • Funds reported $188K of BioPlus Acquisition Corp. Unit stock for Q2 2023, down 98% quarter-over-quarter.
  • 0 funds opened new BioPlus Acquisition Corp. Unit positions in Q2 2023 and 7 closed out, a net change of -7 holders.
  • The largest BioPlus Acquisition Corp. Unit seller in Q2 2023 was HGC Investment Management, an estimated $5.24M sold.

Based on aggregated 13F filings for Q2 2023.